Review
doi: 10.1016/j.ohc.2004.11.002.
Chemotherapy for retinoblastoma
Affiliations
- PMID: 15763191
- DOI: 10.1016/j.ohc.2004.11.002
Item in Clipboard
Review
Chemotherapy for retinoblastoma
Ophthalmol Clin North Am.
2005 Mar.
Abstract
Retinoblastoma is the most common eye cancer in children. Pilot studies of chemotherapy for intraocular retinoblastoma have been reported by several groups, using different combinations, dosages, schedules, and durations of carboplatin, etoposide, or teniposide, with or without vincristine, and with or without cyclosporine to counteract multidrug resistance. All studies of chemotherapy for intraocular retinoblastoma have included consolidation by focal therapy, with or without radiation. Chemotherapy alone reduces tumor size but does not cure retinoblastoma. Focal therapy, consisting of photocoagulation, thermotherapy, cryotherapy, or brachytherapy, is necessary to consolidate chemotherapy response.
Similar articles
-
Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.Pediatr Blood Cancer. 2008 Mar;50(3):567-72. doi: 10.1002/pbc.21301. Pediatr Blood Cancer. 2008. PMID: 17729249 Clinical Trial.
-
Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.Ophthalmology. 2004 Oct;111(10):1917-24. doi: 10.1016/j.ophtha.2004.04.016. Ophthalmology. 2004. PMID: 15465557
-
Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.Am J Ophthalmol. 2004 Sep;138(3):329-37. doi: 10.1016/j.ajo.2004.04.032. Am J Ophthalmol. 2004. PMID: 15364213 Clinical Trial.
-
Overview: chemotherapy for retinoblastoma: an expanding area of clinical research.Med Pediatr Oncol. 2002 Jun;38(6):428-38. doi: 10.1002/mpo.1358. Med Pediatr Oncol. 2002. PMID: 11984806 Review. No abstract available.
-
[Retinoblastoma update--therapy (Part II)].Klin Oczna. 2006;108(4-6):258-62. Klin Oczna. 2006. PMID: 17020008 Review. Polish.
Cited by
-
Multiple Differential Networks Strategy Reveals Carboplatin and Melphalan-Induced Dynamic Module Changes in Retinoblastoma.Med Sci Monit. 2016 May 4;22:1508-15. doi: 10.12659/msm.897877. Med Sci Monit. 2016. PMID: 27144687 Free PMC article.
-
Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma.J Clin Invest. 2012 Feb;122(2):425-34. doi: 10.1172/JCI57114. Epub 2012 Feb 1. J Clin Invest. 2012. PMID: 22293180 Free PMC article. Review.
-
Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma.Biosensors (Basel). 2021 Mar 26;11(4):97. doi: 10.3390/bios11040097. Biosensors (Basel). 2021. PMID: 33810621 Free PMC article. Review.
-
Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma.Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6149-56. doi: 10.1167/iovs.09-5033. Epub 2010 Aug 11. Invest Ophthalmol Vis Sci. 2010. PMID: 20702830 Free PMC article.
-
Basic fibroblast growth factor impact on retinoblastoma progression and survival.Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5215-21. doi: 10.1167/iovs.07-1668. Epub 2008 Jul 9. Invest Ophthalmol Vis Sci. 2008. PMID: 18614803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
